We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ureteral Stent Length and Patient Symptoms

This study has been terminated.
(Because no staff to consent or enroll subjects)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00288457
First Posted: February 8, 2006
Last Update Posted: December 24, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
John G Pattaras, MD, Emory University
  Purpose
The Study of whether or not Ureteral Stent Length affects patient comfort after electro-shock wave treatment for kidney stones.

Condition Intervention
Kidney Stones Device: Ureteral Stent

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by John G Pattaras, MD, Emory University:

Enrollment: 1
Study Start Date: February 2006
Study Completion Date: October 2006
Intervention Details:
    Device: Ureteral Stent
    Ureteral stents are not investigatory but rather part of standard of care. In this study, we were interested in having patients fill out pre and post-operative questionnaires so that we could compare their symptoms with the length of their ureter and the stent placed.
Detailed Description:
Patients undergoing electro shock wave for treatment of kidney stones are randomized to long or short stent length after signing an informed consent prior to their surgery. They keep a pain diary and medication diary for a two week period after the stent is placed. These are turned in at the two week post-op visit. Patients also complete a quality of life and urinary symptom score questionnaire pre and post operatively.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones
Criteria

Inclusion Criteria: Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones -

Exclusion Criteria:Under 18 years of age, inability to give informed consent

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00288457


Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: John G Pattaras, MD Emory University
  More Information

Responsible Party: John G Pattaras, MD, Associate Professor, Emory University
ClinicalTrials.gov Identifier: NCT00288457     History of Changes
Other Study ID Numbers: 0758-2003
First Submitted: February 6, 2006
First Posted: February 8, 2006
Last Update Posted: December 24, 2013
Last Verified: December 2013

Additional relevant MeSH terms:
Kidney Calculi
Nephrolithiasis
Kidney Diseases
Urologic Diseases
Urolithiasis
Urinary Calculi
Calculi
Pathological Conditions, Anatomical